Form 4: Collegium Pharmaceutical Executive Scott Dreyer Executes Stock Options and Sells Shares

EVP & Chief Commercial Officer of Collegium Pharmaceutical, Scott Dreyer, exercised stock options and sold shares on May 23 and 24, 2024.

Summary

• Scott Dreyer, EVP & Chief Commercial Officer of Collegium Pharmaceutical, executed stock options to acquire shares of common stock at a price of $24.03 on May 23 and 24, 2024.
• He then sold these shares on the same days at weighted average prices of $33.824 and $33.9827, respectively.
• On May 23, 51,209 shares were acquired and sold, resulting in a remaining direct ownership of 138,918 shares.
• On May 24, 23,791 shares were acquired and sold, resulting in a remaining direct ownership of 105,902 shares.
• The stock options were fully vested and exercisable as of the transaction dates.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership.

Key Dates